nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—TYMS—head and neck cancer	0.466	1	CbGaD
Pemetrexed—SLC29A1—Fluorouracil—head and neck cancer	0.188	0.519	CbGbCtD
Pemetrexed—TYMS—Fluorouracil—head and neck cancer	0.174	0.481	CbGbCtD
Pemetrexed—Radiation pneumonitis—Docetaxel—head and neck cancer	0.00541	0.0785	CcSEcCtD
Pemetrexed—Odynophagia—Docetaxel—head and neck cancer	0.00311	0.0451	CcSEcCtD
Pemetrexed—GART—One Carbon Metabolism—TYMS—head and neck cancer	0.00251	0.0364	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00248	0.0361	CbGpPWpGaD
Pemetrexed—DHFR—G1/S-Specific Transcription—CCNA1—head and neck cancer	0.00224	0.0326	CbGpPWpGaD
Pemetrexed—Peripheral motor neuropathy—Docetaxel—head and neck cancer	0.00213	0.031	CcSEcCtD
Pemetrexed—GART—Purine metabolism—GPX1—head and neck cancer	0.00208	0.0302	CbGpPWpGaD
Pemetrexed—TYMS—G1/S-Specific Transcription—CCNA1—head and neck cancer	0.00196	0.0284	CbGpPWpGaD
Pemetrexed—GART—Nucleotide metabolism—DPYD—head and neck cancer	0.00194	0.0282	CbGpPWpGaD
Pemetrexed—DCK—Pyrimidine metabolism—DPYD—head and neck cancer	0.00179	0.0261	CbGpPWpGaD
Pemetrexed—ATIC—One Carbon Metabolism—TYMS—head and neck cancer	0.00174	0.0252	CbGpPWpGaD
Pemetrexed—GART—parotid gland—head and neck cancer	0.00173	0.0622	CbGeAlD
Pemetrexed—DHFR—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00168	0.0244	CbGpPWpGaD
Pemetrexed—GART—saliva-secreting gland—head and neck cancer	0.00166	0.0596	CbGeAlD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00165	0.024	CbGpPWpGaD
Pemetrexed—Raltitrexed—TYMS—head and neck cancer	0.00155	0.351	CrCbGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00147	0.0213	CbGpPWpGaD
Pemetrexed—ATIC—Purine metabolism—GPX1—head and neck cancer	0.00144	0.021	CbGpPWpGaD
Pemetrexed—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00136	0.0197	CcSEcCtD
Pemetrexed—ATIC—Nucleotide metabolism—DPYD—head and neck cancer	0.00134	0.0195	CbGpPWpGaD
Pemetrexed—DHFR—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.00132	0.0192	CbGpPWpGaD
Pemetrexed—GART—trachea—head and neck cancer	0.00128	0.046	CbGeAlD
Pemetrexed—Platelet count decreased—Hydroxyurea—head and neck cancer	0.00126	0.0183	CcSEcCtD
Pemetrexed—TYMS—Pyrimidine metabolism—DPYD—head and neck cancer	0.00126	0.0183	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—SOD2—head and neck cancer	0.00125	0.0182	CbGpPWpGaD
Pemetrexed—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00125	0.0181	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—GPX1—head and neck cancer	0.00119	0.0174	CbGpPWpGaD
Pemetrexed—Pralatrexate—TYMS—head and neck cancer	0.00118	0.266	CrCbGaD
Pemetrexed—Leucovorin—TYMS—head and neck cancer	0.00118	0.266	CrCbGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00118	0.0171	CbGpPWpGaD
Pemetrexed—TYMS—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.00115	0.0167	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00112	0.0162	CbGpPWpGaD
Pemetrexed—GART—lymphoid tissue—head and neck cancer	0.00111	0.0401	CbGeAlD
Pemetrexed—GART—Nucleotide metabolism—TYMS—head and neck cancer	0.0011	0.016	CbGpPWpGaD
Pemetrexed—Neuritis—Vinblastine—head and neck cancer	0.0011	0.016	CcSEcCtD
Pemetrexed—TYMS—Paclitaxel—Docetaxel—head and neck cancer	0.00109	0.456	CbGdCrCtD
Pemetrexed—DHFR—G1/S-Specific Transcription—TYMS—head and neck cancer	0.00108	0.0157	CbGpPWpGaD
Pemetrexed—GART—Nucleotide metabolism—GPX1—head and neck cancer	0.00105	0.0152	CbGpPWpGaD
Pemetrexed—ATIC—connective tissue—head and neck cancer	0.00103	0.0372	CbGeAlD
Pemetrexed—DCK—Pyrimidine metabolism—TYMS—head and neck cancer	0.00102	0.0148	CbGpPWpGaD
Pemetrexed—GART—thyroid gland—head and neck cancer	0.00101	0.0364	CbGeAlD
Pemetrexed—ATIC—epithelium—head and neck cancer	0.000983	0.0353	CbGeAlD
Pemetrexed—TYMS—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000974	0.0142	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000941	0.0137	CbGpPWpGaD
Pemetrexed—Rectal haemorrhage—Vinblastine—head and neck cancer	0.000911	0.0132	CcSEcCtD
Pemetrexed—SLC46A1—lymphoid tissue—head and neck cancer	0.000905	0.0325	CbGeAlD
Pemetrexed—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000898	0.013	CcSEcCtD
Pemetrexed—GART—head—head and neck cancer	0.000898	0.0323	CbGeAlD
Pemetrexed—SLC46A1—thyroid gland—head and neck cancer	0.000822	0.0295	CbGeAlD
Pemetrexed—Interstitial pneumonia—Docetaxel—head and neck cancer	0.000807	0.0117	CcSEcCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000795	0.0116	CbGpPWpGaD
Pemetrexed—DHFR—E2F transcription factor network—CEBPA—head and neck cancer	0.000794	0.0115	CbGpPWpGaD
Pemetrexed—Creatinine increased—Hydroxyurea—head and neck cancer	0.000788	0.0114	CcSEcCtD
Pemetrexed—Heartburn—Fluorouracil—head and neck cancer	0.000785	0.0114	CcSEcCtD
Pemetrexed—ATIC—Nucleotide metabolism—TYMS—head and neck cancer	0.000765	0.0111	CbGpPWpGaD
Pemetrexed—ATIC—lymphoid tissue—head and neck cancer	0.000757	0.0272	CbGeAlD
Pemetrexed—DHFR—saliva-secreting gland—head and neck cancer	0.000756	0.0272	CbGeAlD
Pemetrexed—DCK—Purine metabolism—GPX1—head and neck cancer	0.000749	0.0109	CbGpPWpGaD
Pemetrexed—SLC46A1—head—head and neck cancer	0.000729	0.0262	CbGeAlD
Pemetrexed—DHFR—One Carbon Metabolism—TYMS—head and neck cancer	0.000726	0.0105	CbGpPWpGaD
Pemetrexed—ATIC—Nucleotide metabolism—GPX1—head and neck cancer	0.000724	0.0105	CbGpPWpGaD
Pemetrexed—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000717	0.0104	CcSEcCtD
Pemetrexed—Mucosal inflammation—Docetaxel—head and neck cancer	0.000704	0.0102	CcSEcCtD
Pemetrexed—TYMS—connective tissue—head and neck cancer	0.000702	0.0252	CbGeAlD
Pemetrexed—TYMS—Vinorelbine—Vinblastine—head and neck cancer	0.0007	0.293	CbGdCrCtD
Pemetrexed—DCK—Nucleotide metabolism—DPYD—head and neck cancer	0.000698	0.0101	CbGpPWpGaD
Pemetrexed—DHFR—connective tissue—head and neck cancer	0.000695	0.025	CbGeAlD
Pemetrexed—TYMS—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000693	0.0101	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—CEBPA—head and neck cancer	0.000692	0.0101	CbGpPWpGaD
Pemetrexed—ATIC—thyroid gland—head and neck cancer	0.000687	0.0247	CbGeAlD
Pemetrexed—DCK—parotid gland—head and neck cancer	0.000683	0.0246	CbGeAlD
Pemetrexed—SLC46A1—Folate Metabolism—SOD2—head and neck cancer	0.000676	0.00983	CbGpPWpGaD
Pemetrexed—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.000672	0.00975	CcSEcCtD
Pemetrexed—DCK—saliva-secreting gland—head and neck cancer	0.000654	0.0235	CbGeAlD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—head and neck cancer	0.000652	0.00948	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL2—head and neck cancer	0.000652	0.00947	CbGpPWpGaD
Pemetrexed—Febrile neutropenia—Docetaxel—head and neck cancer	0.000648	0.0094	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—XRCC1—head and neck cancer	0.000647	0.0094	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—GPX1—head and neck cancer	0.000645	0.00938	CbGpPWpGaD
Pemetrexed—DHFR—E2F mediated regulation of DNA replication—TYMS—head and neck cancer	0.000636	0.00925	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000636	0.00925	CbGpPWpGaD
Pemetrexed—SLC29A1—connective tissue—head and neck cancer	0.000629	0.0226	CbGeAlD
Pemetrexed—GART—lymph node—head and neck cancer	0.000629	0.0226	CbGeAlD
Pemetrexed—ATIC—head—head and neck cancer	0.00061	0.0219	CbGeAlD
Pemetrexed—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00061	0.00884	CcSEcCtD
Pemetrexed—Embolism—Docetaxel—head and neck cancer	0.000607	0.00881	CcSEcCtD
Pemetrexed—TYMS—Vincristine—Vinblastine—head and neck cancer	0.000598	0.251	CbGdCrCtD
Pemetrexed—Renal failure acute—Hydroxyurea—head and neck cancer	0.00059	0.00856	CcSEcCtD
Pemetrexed—Lacrimation increased—Fluorouracil—head and neck cancer	0.000586	0.0085	CcSEcCtD
Pemetrexed—DHFR—trachea—head and neck cancer	0.000583	0.021	CbGeAlD
Pemetrexed—Haemoglobin decreased—Docetaxel—head and neck cancer	0.000567	0.00822	CcSEcCtD
Pemetrexed—Heartburn—Docetaxel—head and neck cancer	0.000567	0.00822	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—XRCC1—head and neck cancer	0.000564	0.0082	CbGpPWpGaD
Pemetrexed—Interstitial lung disease—Docetaxel—head and neck cancer	0.000551	0.00799	CcSEcCtD
Pemetrexed—SLC29A1—trachea—head and neck cancer	0.000528	0.019	CbGeAlD
Pemetrexed—Neuritis—Docetaxel—head and neck cancer	0.000522	0.00757	CcSEcCtD
Pemetrexed—Methotrexate—TYMS—head and neck cancer	0.000519	0.117	CrCbGaD
Pemetrexed—TYMS—lymphoid tissue—head and neck cancer	0.000513	0.0184	CbGeAlD
Pemetrexed—SLC46A1—lymph node—head and neck cancer	0.00051	0.0183	CbGeAlD
Pemetrexed—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00051	0.0074	CcSEcCtD
Pemetrexed—DHFR—lymphoid tissue—head and neck cancer	0.000508	0.0183	CbGeAlD
Pemetrexed—DHFR—G1/S Transition—CCNA1—head and neck cancer	0.000507	0.00737	CbGpPWpGaD
Pemetrexed—DCK—trachea—head and neck cancer	0.000505	0.0181	CbGeAlD
Pemetrexed—Angina pectoris—Vinblastine—head and neck cancer	0.000503	0.00729	CcSEcCtD
Pemetrexed—Oesophagitis—Fluorouracil—head and neck cancer	0.000494	0.00716	CcSEcCtD
Pemetrexed—Pancytopenia—Vinblastine—head and neck cancer	0.00049	0.00711	CcSEcCtD
Pemetrexed—TYMS—Nucleotide metabolism—DPYD—head and neck cancer	0.00049	0.00712	CbGpPWpGaD
Pemetrexed—Myocardial ischaemia—Docetaxel—head and neck cancer	0.000485	0.00703	CcSEcCtD
Pemetrexed—GART—Metabolism—UROD—head and neck cancer	0.000483	0.00703	CbGpPWpGaD
Pemetrexed—Sepsis—Fluorouracil—head and neck cancer	0.000469	0.0068	CcSEcCtD
Pemetrexed—TYMS—thyroid gland—head and neck cancer	0.000466	0.0168	CbGeAlD
Pemetrexed—Pancreatitis—Hydroxyurea—head and neck cancer	0.000462	0.00669	CcSEcCtD
Pemetrexed—DHFR—thyroid gland—head and neck cancer	0.000462	0.0166	CbGeAlD
Pemetrexed—SLC29A1—lymphoid tissue—head and neck cancer	0.00046	0.0165	CbGeAlD
Pemetrexed—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000454	0.00658	CcSEcCtD
Pemetrexed—Myocardial infarction—Vinblastine—head and neck cancer	0.000451	0.00654	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000451	0.00654	CcSEcCtD
Pemetrexed—Pancytopenia—Hydroxyurea—head and neck cancer	0.000447	0.00648	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—CCNA1—head and neck cancer	0.000442	0.00643	CbGpPWpGaD
Pemetrexed—Neutropenia—Hydroxyurea—head and neck cancer	0.00044	0.00639	CcSEcCtD
Pemetrexed—DCK—lymphoid tissue—head and neck cancer	0.00044	0.0158	CbGeAlD
Pemetrexed—Agranulocytosis—Vinblastine—head and neck cancer	0.00043	0.00623	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000427	0.00621	CbGpPWpGaD
Pemetrexed—ATIC—lymph node—head and neck cancer	0.000427	0.0153	CbGeAlD
Pemetrexed—Lacrimation increased—Docetaxel—head and neck cancer	0.000423	0.00614	CcSEcCtD
Pemetrexed—Infestation—Hydroxyurea—head and neck cancer	0.00042	0.00609	CcSEcCtD
Pemetrexed—Infestation NOS—Hydroxyurea—head and neck cancer	0.00042	0.00609	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—TP53—head and neck cancer	0.000419	0.00608	CbGpPWpGaD
Pemetrexed—SLC29A1—thyroid gland—head and neck cancer	0.000418	0.015	CbGeAlD
Pemetrexed—TYMS—head—head and neck cancer	0.000414	0.0149	CbGeAlD
Pemetrexed—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000412	0.00597	CcSEcCtD
Pemetrexed—Pharyngitis—Vinblastine—head and neck cancer	0.00041	0.00595	CcSEcCtD
Pemetrexed—DHFR—head—head and neck cancer	0.000409	0.0147	CbGeAlD
Pemetrexed—Stomatitis—Hydroxyurea—head and neck cancer	0.000409	0.00593	CcSEcCtD
Pemetrexed—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—head and neck cancer	0.0004	0.00582	CbGpPWpGaD
Pemetrexed—DCK—thyroid gland—head and neck cancer	0.000399	0.0144	CbGeAlD
Pemetrexed—DCK—Nucleotide metabolism—TYMS—head and neck cancer	0.000398	0.00578	CbGpPWpGaD
Pemetrexed—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000397	0.00576	CcSEcCtD
Pemetrexed—Respiratory failure—Docetaxel—head and neck cancer	0.000397	0.00576	CcSEcCtD
Pemetrexed—Pulmonary embolism—Docetaxel—head and neck cancer	0.00039	0.00565	CcSEcCtD
Pemetrexed—DCK—Nucleotide metabolism—GPX1—head and neck cancer	0.000377	0.00547	CbGpPWpGaD
Pemetrexed—Colitis—Docetaxel—head and neck cancer	0.000374	0.00543	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000373	0.00542	CbGpPWpGaD
Pemetrexed—Skin exfoliation—Docetaxel—head and neck cancer	0.000372	0.0054	CcSEcCtD
Pemetrexed—SLC29A1—head—head and neck cancer	0.000371	0.0133	CbGeAlD
Pemetrexed—Neuropathy—Docetaxel—head and neck cancer	0.000366	0.00531	CcSEcCtD
Pemetrexed—Alopecia—Vinblastine—head and neck cancer	0.000365	0.0053	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000365	0.0053	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—SOD2—head and neck cancer	0.000363	0.00527	CbGpPWpGaD
Pemetrexed—Oesophagitis—Docetaxel—head and neck cancer	0.000356	0.00517	CcSEcCtD
Pemetrexed—DCK—head—head and neck cancer	0.000354	0.0127	CbGeAlD
Pemetrexed—SLC46A1—Folate Metabolism—IL2—head and neck cancer	0.000352	0.00512	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—GPX1—head and neck cancer	0.000346	0.00503	CbGpPWpGaD
Pemetrexed—Dysphagia—Fluorouracil—head and neck cancer	0.000339	0.00492	CcSEcCtD
Pemetrexed—Sepsis—Docetaxel—head and neck cancer	0.000338	0.00491	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—TYMS—head and neck cancer	0.000337	0.0049	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—UROD—head and neck cancer	0.000335	0.00487	CbGpPWpGaD
Pemetrexed—Alopecia—Hydroxyurea—head and neck cancer	0.000333	0.00483	CcSEcCtD
Pemetrexed—Anaemia—Vinblastine—head and neck cancer	0.000333	0.00482	CcSEcCtD
Pemetrexed—Angina pectoris—Fluorouracil—head and neck cancer	0.00033	0.00479	CcSEcCtD
Pemetrexed—Erythema—Hydroxyurea—head and neck cancer	0.000328	0.00476	CcSEcCtD
Pemetrexed—Leukopenia—Vinblastine—head and neck cancer	0.000322	0.00467	CcSEcCtD
Pemetrexed—Pancytopenia—Fluorouracil—head and neck cancer	0.000322	0.00467	CcSEcCtD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000312	0.00454	CbGpPWpGaD
Pemetrexed—Hypertension—Vinblastine—head and neck cancer	0.000311	0.0045	CcSEcCtD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000304	0.00443	CbGpPWpGaD
Pemetrexed—Anaemia—Hydroxyurea—head and neck cancer	0.000303	0.0044	CcSEcCtD
Pemetrexed—Infestation—Fluorouracil—head and neck cancer	0.000302	0.00438	CcSEcCtD
Pemetrexed—Infestation NOS—Fluorouracil—head and neck cancer	0.000302	0.00438	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000298	0.00432	CcSEcCtD
Pemetrexed—Myocardial infarction—Fluorouracil—head and neck cancer	0.000296	0.0043	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000296	0.0043	CcSEcCtD
Pemetrexed—Stomatitis—Fluorouracil—head and neck cancer	0.000295	0.00427	CcSEcCtD
Pemetrexed—Conjunctivitis—Fluorouracil—head and neck cancer	0.000294	0.00426	CcSEcCtD
Pemetrexed—Leukopenia—Hydroxyurea—head and neck cancer	0.000294	0.00426	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000293	0.00426	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000293	0.00426	CbGpPWpGaD
Pemetrexed—TYMS—lymph node—head and neck cancer	0.00029	0.0104	CbGeAlD
Pemetrexed—Thrombocytopenia—Vinblastine—head and neck cancer	0.000287	0.00417	CcSEcCtD
Pemetrexed—DHFR—lymph node—head and neck cancer	0.000287	0.0103	CbGeAlD
Pemetrexed—Agranulocytosis—Fluorouracil—head and neck cancer	0.000282	0.00409	CcSEcCtD
Pemetrexed—Anorexia—Vinblastine—head and neck cancer	0.00028	0.00406	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000277	0.00402	CcSEcCtD
Pemetrexed—DHFR—Metabolism of nitric oxide—AKT1—head and neck cancer	0.000277	0.00403	CbGpPWpGaD
Pemetrexed—Pharyngitis—Fluorouracil—head and neck cancer	0.000269	0.0039	CcSEcCtD
Pemetrexed—Oedema—Hydroxyurea—head and neck cancer	0.000268	0.00388	CcSEcCtD
Pemetrexed—Infection—Hydroxyurea—head and neck cancer	0.000266	0.00386	CcSEcCtD
Pemetrexed—TYMS—Nucleotide metabolism—GPX1—head and neck cancer	0.000264	0.00384	CbGpPWpGaD
Pemetrexed—Dehydration—Docetaxel—head and neck cancer	0.000263	0.00382	CcSEcCtD
Pemetrexed—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000263	0.00381	CcSEcCtD
Pemetrexed—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000262	0.0038	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—UROD—head and neck cancer	0.000261	0.00379	CbGpPWpGaD
Pemetrexed—Skin disorder—Hydroxyurea—head and neck cancer	0.00026	0.00377	CcSEcCtD
Pemetrexed—SLC29A1—lymph node—head and neck cancer	0.00026	0.00933	CbGeAlD
Pemetrexed—Anorexia—Hydroxyurea—head and neck cancer	0.000255	0.0037	CcSEcCtD
Pemetrexed—Decreased appetite—Vinblastine—head and neck cancer	0.000255	0.0037	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000255	0.0037	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000255	0.0037	CcSEcCtD
Pemetrexed—Constipation—Vinblastine—head and neck cancer	0.000251	0.00364	CcSEcCtD
Pemetrexed—Pain—Vinblastine—head and neck cancer	0.000251	0.00364	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00025	0.00362	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000249	0.00363	CbGpPWpGaD
Pemetrexed—DCK—lymph node—head and neck cancer	0.000248	0.00892	CbGeAlD
Pemetrexed—DHFR—G1/S Transition—TYMS—head and neck cancer	0.000245	0.00356	CbGpPWpGaD
Pemetrexed—Dysphagia—Docetaxel—head and neck cancer	0.000245	0.00355	CcSEcCtD
Pemetrexed—Arrhythmia—Fluorouracil—head and neck cancer	0.000242	0.00351	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00024	0.00348	CcSEcCtD
Pemetrexed—Alopecia—Fluorouracil—head and neck cancer	0.00024	0.00348	CcSEcCtD
Pemetrexed—Dyspnoea—Hydroxyurea—head and neck cancer	0.000239	0.00346	CcSEcCtD
Pemetrexed—Angina pectoris—Docetaxel—head and neck cancer	0.000238	0.00346	CcSEcCtD
Pemetrexed—Erythema—Fluorouracil—head and neck cancer	0.000236	0.00342	CcSEcCtD
Pemetrexed—Dyspepsia—Hydroxyurea—head and neck cancer	0.000236	0.00342	CcSEcCtD
Pemetrexed—Decreased appetite—Hydroxyurea—head and neck cancer	0.000233	0.00338	CcSEcCtD
Pemetrexed—Pancytopenia—Docetaxel—head and neck cancer	0.000232	0.00337	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000232	0.00337	CbGpPWpGaD
Pemetrexed—Abdominal pain—Vinblastine—head and neck cancer	0.000232	0.00337	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000231	0.00335	CcSEcCtD
Pemetrexed—Fatigue—Hydroxyurea—head and neck cancer	0.000231	0.00335	CcSEcCtD
Pemetrexed—Constipation—Hydroxyurea—head and neck cancer	0.000229	0.00332	CcSEcCtD
Pemetrexed—Pain—Hydroxyurea—head and neck cancer	0.000229	0.00332	CcSEcCtD
Pemetrexed—Neutropenia—Docetaxel—head and neck cancer	0.000229	0.00332	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000227	0.0033	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—head and neck cancer	0.000226	0.00329	CbGpPWpGaD
Pemetrexed—Anaemia—Fluorouracil—head and neck cancer	0.000218	0.00317	CcSEcCtD
Pemetrexed—Infestation—Docetaxel—head and neck cancer	0.000218	0.00316	CcSEcCtD
Pemetrexed—Infestation NOS—Docetaxel—head and neck cancer	0.000218	0.00316	CcSEcCtD
Pemetrexed—Hypersensitivity—Vinblastine—head and neck cancer	0.000216	0.00314	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000216	0.00314	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000215	0.00312	CcSEcCtD
Pemetrexed—Renal failure—Docetaxel—head and neck cancer	0.000214	0.00311	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000214	0.0031	CcSEcCtD
Pemetrexed—Myocardial infarction—Docetaxel—head and neck cancer	0.000214	0.0031	CcSEcCtD
Pemetrexed—Stomatitis—Docetaxel—head and neck cancer	0.000213	0.00308	CcSEcCtD
Pemetrexed—Conjunctivitis—Docetaxel—head and neck cancer	0.000212	0.00307	CcSEcCtD
Pemetrexed—Body temperature increased—Hydroxyurea—head and neck cancer	0.000212	0.00307	CcSEcCtD
Pemetrexed—Leukopenia—Fluorouracil—head and neck cancer	0.000211	0.00307	CcSEcCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000211	0.00307	CbGpPWpGaD
Pemetrexed—Asthenia—Vinblastine—head and neck cancer	0.000211	0.00306	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000206	0.00299	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000206	0.003	CbGpPWpGaD
Pemetrexed—Agranulocytosis—Docetaxel—head and neck cancer	0.000204	0.00295	CcSEcCtD
Pemetrexed—Chest pain—Fluorouracil—head and neck cancer	0.000201	0.00292	CcSEcCtD
Pemetrexed—Myalgia—Fluorouracil—head and neck cancer	0.000201	0.00292	CcSEcCtD
Pemetrexed—Diarrhoea—Vinblastine—head and neck cancer	0.000201	0.00291	CcSEcCtD
Pemetrexed—GART—Metabolism—NAT2—head and neck cancer	0.000201	0.00292	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000197	0.00286	CcSEcCtD
Pemetrexed—Hepatitis—Docetaxel—head and neck cancer	0.000196	0.00284	CcSEcCtD
Pemetrexed—Pharyngitis—Docetaxel—head and neck cancer	0.000194	0.00282	CcSEcCtD
Pemetrexed—Dizziness—Vinblastine—head and neck cancer	0.000194	0.00282	CcSEcCtD
Pemetrexed—Urinary tract disorder—Docetaxel—head and neck cancer	0.000193	0.0028	CcSEcCtD
Pemetrexed—Oedema—Fluorouracil—head and neck cancer	0.000193	0.0028	CcSEcCtD
Pemetrexed—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000193	0.0028	CcSEcCtD
Pemetrexed—Asthenia—Hydroxyurea—head and neck cancer	0.000192	0.00279	CcSEcCtD
Pemetrexed—Urethral disorder—Docetaxel—head and neck cancer	0.000192	0.00278	CcSEcCtD
Pemetrexed—Infection—Fluorouracil—head and neck cancer	0.000191	0.00278	CcSEcCtD
Pemetrexed—Nervous system disorder—Fluorouracil—head and neck cancer	0.000189	0.00274	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL2—head and neck cancer	0.000189	0.00274	CbGpPWpGaD
Pemetrexed—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000189	0.00274	CcSEcCtD
Pemetrexed—Vomiting—Vinblastine—head and neck cancer	0.000187	0.00271	CcSEcCtD
Pemetrexed—Erythema multiforme—Docetaxel—head and neck cancer	0.000185	0.00268	CcSEcCtD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000184	0.00268	CbGpPWpGaD
Pemetrexed—Anorexia—Fluorouracil—head and neck cancer	0.000184	0.00266	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000184	0.00267	CbGpPWpGaD
Pemetrexed—Diarrhoea—Hydroxyurea—head and neck cancer	0.000183	0.00266	CcSEcCtD
Pemetrexed—Eye disorder—Docetaxel—head and neck cancer	0.000183	0.00265	CcSEcCtD
Pemetrexed—Dizziness—Hydroxyurea—head and neck cancer	0.000177	0.00257	CcSEcCtD
Pemetrexed—GART—Metabolism—DPYD—head and neck cancer	0.000176	0.00256	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000176	0.00255	CcSEcCtD
Pemetrexed—Arrhythmia—Docetaxel—head and neck cancer	0.000175	0.00254	CcSEcCtD
Pemetrexed—Nausea—Vinblastine—head and neck cancer	0.000174	0.00253	CcSEcCtD
Pemetrexed—DCK—Metabolism—UROD—head and neck cancer	0.000174	0.00253	CbGpPWpGaD
Pemetrexed—Alopecia—Docetaxel—head and neck cancer	0.000173	0.00251	CcSEcCtD
Pemetrexed—Dyspnoea—Fluorouracil—head and neck cancer	0.000172	0.00249	CcSEcCtD
Pemetrexed—Malnutrition—Docetaxel—head and neck cancer	0.00017	0.00247	CcSEcCtD
Pemetrexed—Erythema—Docetaxel—head and neck cancer	0.00017	0.00247	CcSEcCtD
Pemetrexed—Vomiting—Hydroxyurea—head and neck cancer	0.00017	0.00247	CcSEcCtD
Pemetrexed—Dyspepsia—Fluorouracil—head and neck cancer	0.00017	0.00246	CcSEcCtD
Pemetrexed—Rash—Hydroxyurea—head and neck cancer	0.000169	0.00245	CcSEcCtD
Pemetrexed—Dermatitis—Hydroxyurea—head and neck cancer	0.000169	0.00245	CcSEcCtD
Pemetrexed—Decreased appetite—Fluorouracil—head and neck cancer	0.000168	0.00243	CcSEcCtD
Pemetrexed—GART—Metabolism—YAP1—head and neck cancer	0.000167	0.00243	CbGpPWpGaD
Pemetrexed—Dysgeusia—Docetaxel—head and neck cancer	0.000167	0.00242	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000166	0.00241	CcSEcCtD
Pemetrexed—Pain—Fluorouracil—head and neck cancer	0.000165	0.00239	CcSEcCtD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000163	0.00237	CbGpPWpGaD
Pemetrexed—Nausea—Hydroxyurea—head and neck cancer	0.000159	0.00231	CcSEcCtD
Pemetrexed—Anaemia—Docetaxel—head and neck cancer	0.000158	0.00228	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000157	0.00228	CbGpPWpGaD
Pemetrexed—Urticaria—Fluorouracil—head and neck cancer	0.000153	0.00222	CcSEcCtD
Pemetrexed—Syncope—Docetaxel—head and neck cancer	0.000153	0.00222	CcSEcCtD
Pemetrexed—Leukopenia—Docetaxel—head and neck cancer	0.000153	0.00221	CcSEcCtD
Pemetrexed—Body temperature increased—Fluorouracil—head and neck cancer	0.000152	0.00221	CcSEcCtD
Pemetrexed—Loss of consciousness—Docetaxel—head and neck cancer	0.00015	0.00217	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000148	0.00214	CbGpPWpGaD
Pemetrexed—Hypertension—Docetaxel—head and neck cancer	0.000147	0.00213	CcSEcCtD
Pemetrexed—Arthralgia—Docetaxel—head and neck cancer	0.000145	0.0021	CcSEcCtD
Pemetrexed—Myalgia—Docetaxel—head and neck cancer	0.000145	0.0021	CcSEcCtD
Pemetrexed—Chest pain—Docetaxel—head and neck cancer	0.000145	0.0021	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000144	0.00209	CcSEcCtD
Pemetrexed—Hypersensitivity—Fluorouracil—head and neck cancer	0.000142	0.00206	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—CCNA1—head and neck cancer	0.00014	0.00204	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—UROD—head and neck cancer	0.00014	0.00203	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NAT2—head and neck cancer	0.000139	0.00202	CbGpPWpGaD
Pemetrexed—Oedema—Docetaxel—head and neck cancer	0.000139	0.00202	CcSEcCtD
Pemetrexed—Anaphylactic shock—Docetaxel—head and neck cancer	0.000139	0.00202	CcSEcCtD
Pemetrexed—Infection—Docetaxel—head and neck cancer	0.000138	0.002	CcSEcCtD
Pemetrexed—Shock—Docetaxel—head and neck cancer	0.000137	0.00198	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000137	0.00199	CbGpPWpGaD
Pemetrexed—Nervous system disorder—Docetaxel—head and neck cancer	0.000136	0.00198	CcSEcCtD
Pemetrexed—Pruritus—Fluorouracil—head and neck cancer	0.000136	0.00198	CcSEcCtD
Pemetrexed—Thrombocytopenia—Docetaxel—head and neck cancer	0.000136	0.00198	CcSEcCtD
Pemetrexed—Skin disorder—Docetaxel—head and neck cancer	0.000135	0.00196	CcSEcCtD
Pemetrexed—Anorexia—Docetaxel—head and neck cancer	0.000133	0.00192	CcSEcCtD
Pemetrexed—Diarrhoea—Fluorouracil—head and neck cancer	0.000132	0.00191	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000129	0.00187	CbGpPWpGaD
Pemetrexed—Dizziness—Fluorouracil—head and neck cancer	0.000127	0.00185	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000127	0.00184	CcSEcCtD
Pemetrexed—Dyspnoea—Docetaxel—head and neck cancer	0.000124	0.0018	CcSEcCtD
Pemetrexed—Vomiting—Fluorouracil—head and neck cancer	0.000123	0.00178	CcSEcCtD
Pemetrexed—Dyspepsia—Docetaxel—head and neck cancer	0.000122	0.00178	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—CCNA1—head and neck cancer	0.000122	0.00178	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—UROD—head and neck cancer	0.000122	0.00178	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—DPYD—head and neck cancer	0.000122	0.00177	CbGpPWpGaD
Pemetrexed—Rash—Fluorouracil—head and neck cancer	0.000122	0.00176	CcSEcCtD
Pemetrexed—Dermatitis—Fluorouracil—head and neck cancer	0.000121	0.00176	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TP53—head and neck cancer	0.000121	0.00176	CbGpPWpGaD
Pemetrexed—Decreased appetite—Docetaxel—head and neck cancer	0.000121	0.00175	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	0.000121	0.00176	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00012	0.00174	CcSEcCtD
Pemetrexed—Fatigue—Docetaxel—head and neck cancer	0.00012	0.00174	CcSEcCtD
Pemetrexed—Constipation—Docetaxel—head and neck cancer	0.000119	0.00173	CcSEcCtD
Pemetrexed—Pain—Docetaxel—head and neck cancer	0.000119	0.00173	CcSEcCtD
Pemetrexed—ATIC—Metabolism—YAP1—head and neck cancer	0.000116	0.00168	CbGpPWpGaD
Pemetrexed—Nausea—Fluorouracil—head and neck cancer	0.000114	0.00166	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000114	0.00165	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—RAD51—head and neck cancer	0.000113	0.00164	CbGpPWpGaD
Pemetrexed—Body temperature increased—Docetaxel—head and neck cancer	0.00011	0.00159	CcSEcCtD
Pemetrexed—Abdominal pain—Docetaxel—head and neck cancer	0.00011	0.00159	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—NAT2—head and neck cancer	0.000108	0.00158	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CCND1—head and neck cancer	0.000104	0.00151	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Docetaxel—head and neck cancer	0.000102	0.00149	CcSEcCtD
Pemetrexed—GART—Metabolism—TYMS—head and neck cancer	0.0001	0.00146	CbGpPWpGaD
Pemetrexed—Asthenia—Docetaxel—head and neck cancer	9.98e-05	0.00145	CcSEcCtD
Pemetrexed—GART—Metabolism—GSTM1—head and neck cancer	9.92e-05	0.00144	CbGpPWpGaD
Pemetrexed—Pruritus—Docetaxel—head and neck cancer	9.84e-05	0.00143	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—RAD51—head and neck cancer	9.82e-05	0.00143	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	9.72e-05	0.00141	CbGpPWpGaD
Pemetrexed—Diarrhoea—Docetaxel—head and neck cancer	9.52e-05	0.00138	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—DPYD—head and neck cancer	9.51e-05	0.00138	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GPX1—head and neck cancer	9.5e-05	0.00138	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP1A1—head and neck cancer	9.4e-05	0.00137	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.32e-05	0.00135	CbGpPWpGaD
Pemetrexed—Dizziness—Docetaxel—head and neck cancer	9.2e-05	0.00133	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CCND1—head and neck cancer	9.06e-05	0.00132	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—YAP1—head and neck cancer	9.02e-05	0.00131	CbGpPWpGaD
Pemetrexed—Vomiting—Docetaxel—head and neck cancer	8.84e-05	0.00128	CcSEcCtD
Pemetrexed—Rash—Docetaxel—head and neck cancer	8.77e-05	0.00127	CcSEcCtD
Pemetrexed—Dermatitis—Docetaxel—head and neck cancer	8.76e-05	0.00127	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	8.48e-05	0.00123	CbGpPWpGaD
Pemetrexed—Nausea—Docetaxel—head and neck cancer	8.26e-05	0.0012	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.99e-05	0.00116	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	7.59e-05	0.0011	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—TYMS—head and neck cancer	7.56e-05	0.0011	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NAT2—head and neck cancer	7.23e-05	0.00105	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—TYMS—head and neck cancer	6.95e-05	0.00101	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTM1—head and neck cancer	6.87e-05	0.000999	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.86e-05	0.000997	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TYMS—head and neck cancer	6.76e-05	0.000983	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.62e-05	0.000963	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GPX1—head and neck cancer	6.58e-05	0.000957	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP1A1—head and neck cancer	6.52e-05	0.000947	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—PTEN—head and neck cancer	6.36e-05	0.000924	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—DPYD—head and neck cancer	6.34e-05	0.000922	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—YAP1—head and neck cancer	6.02e-05	0.000875	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.98e-05	0.000869	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NAT2—head and neck cancer	5.81e-05	0.000845	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.66e-05	0.000822	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—head and neck cancer	5.59e-05	0.000812	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—TYMS—head and neck cancer	5.42e-05	0.000787	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.38e-05	0.000783	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.38e-05	0.000782	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTM1—head and neck cancer	5.35e-05	0.000778	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GPX1—head and neck cancer	5.13e-05	0.000745	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—DPYD—head and neck cancer	5.1e-05	0.000741	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP1A1—head and neck cancer	5.08e-05	0.000738	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NAT2—head and neck cancer	5.07e-05	0.000737	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTEN—head and neck cancer	4.87e-05	0.000709	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOTCH1—head and neck cancer	4.85e-05	0.000706	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—YAP1—head and neck cancer	4.84e-05	0.000703	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.67e-05	0.000679	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.52e-05	0.000657	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DPYD—head and neck cancer	4.45e-05	0.000646	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—head and neck cancer	4.34e-05	0.000631	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—YAP1—head and neck cancer	4.22e-05	0.000613	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—head and neck cancer	3.87e-05	0.000563	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.82e-05	0.000555	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.81e-05	0.000553	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TYMS—head and neck cancer	3.61e-05	0.000525	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—head and neck cancer	3.6e-05	0.000524	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—head and neck cancer	3.57e-05	0.000519	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—head and neck cancer	3.44e-05	0.0005	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX1—head and neck cancer	3.42e-05	0.000497	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND1—head and neck cancer	3.4e-05	0.000495	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1A1—head and neck cancer	3.39e-05	0.000492	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTEN—head and neck cancer	3.38e-05	0.000491	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.32e-05	0.000483	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTEN—head and neck cancer	3.14e-05	0.000457	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK3—head and neck cancer	3.14e-05	0.000456	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—head and neck cancer	3.02e-05	0.000439	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.99e-05	0.000434	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND1—head and neck cancer	2.97e-05	0.000432	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TYMS—head and neck cancer	2.9e-05	0.000422	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—head and neck cancer	2.87e-05	0.000417	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—head and neck cancer	2.81e-05	0.000409	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—head and neck cancer	2.81e-05	0.000408	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK3—head and neck cancer	2.81e-05	0.000408	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX1—head and neck cancer	2.75e-05	0.0004	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.74e-05	0.000398	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1A1—head and neck cancer	2.72e-05	0.000396	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK3—head and neck cancer	2.69e-05	0.00039	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK1—head and neck cancer	2.67e-05	0.000388	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTEN—head and neck cancer	2.63e-05	0.000383	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.61e-05	0.000379	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOTCH1—head and neck cancer	2.6e-05	0.000378	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK1—head and neck cancer	2.56e-05	0.000371	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—head and neck cancer	2.55e-05	0.000371	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—head and neck cancer	2.51e-05	0.000364	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK3—head and neck cancer	2.45e-05	0.000356	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX1—head and neck cancer	2.4e-05	0.000349	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—head and neck cancer	2.38e-05	0.000346	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1A1—head and neck cancer	2.37e-05	0.000345	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK1—head and neck cancer	2.33e-05	0.000339	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—head and neck cancer	2.24e-05	0.000326	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—head and neck cancer	2.22e-05	0.000322	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—head and neck cancer	2.05e-05	0.000298	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—head and neck cancer	2.01e-05	0.000293	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—head and neck cancer	1.96e-05	0.000284	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—head and neck cancer	1.95e-05	0.000283	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—head and neck cancer	1.93e-05	0.000281	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—head and neck cancer	1.86e-05	0.00027	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—head and neck cancer	1.81e-05	0.000263	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTEN—head and neck cancer	1.76e-05	0.000255	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTEN—head and neck cancer	1.69e-05	0.000245	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—head and neck cancer	1.62e-05	0.000235	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—head and neck cancer	1.52e-05	0.000221	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—head and neck cancer	1.51e-05	0.000219	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK3—head and neck cancer	1.44e-05	0.000209	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—head and neck cancer	1.41e-05	0.000205	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTEN—head and neck cancer	1.41e-05	0.000205	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK1—head and neck cancer	1.37e-05	0.000199	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—head and neck cancer	1.37e-05	0.000199	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—head and neck cancer	1.24e-05	0.00018	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTEN—head and neck cancer	1.23e-05	0.000179	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—head and neck cancer	1.19e-05	0.000173	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—head and neck cancer	1.1e-05	0.00016	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—head and neck cancer	1.01e-05	0.000147	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—head and neck cancer	9.96e-06	0.000145	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—head and neck cancer	9.71e-06	0.000141	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—head and neck cancer	8.69e-06	0.000126	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—head and neck cancer	8.13e-06	0.000118	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—head and neck cancer	7.1e-06	0.000103	CbGpPWpGaD
